This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1978 Sep;28(9 Pt 2):132-9.

doi: 10.1212/wnl.28.9_part_2.132.

A review of systemic nonspecific immunosuppressive treatment of multiple sclerosis

G W Ellison, L W Myers

PMID: 213744
DOI: 10.1212/wnl.28.9_part_2.132

Review

A review of systemic nonspecific immunosuppressive treatment of multiple sclerosis

G W Ellison et al. Neurology. 1978 Sep.

. 1978 Sep;28(9 Pt 2):132-9.

doi: 10.1212/wnl.28.9_part_2.132.

Authors

G W Ellison, L W Myers

PMID: 213744
DOI: 10.1212/wnl.28.9_part_2.132

No abstract available

PubMed Disclaimer

Similar articles

Therapeutic trials in multiple sclerosis.
Noseworthy JH, Seland TP, Ebers GC. Noseworthy JH, et al. Can J Neurol Sci. 1984 Aug;11(3):355-62. doi: 10.1017/s0317167100045704. Can J Neurol Sci. 1984. PMID: 6205737 Clinical Trial. No abstract available.
Immunosuppressive treatment of multiple sclerosis.
Carter JL, Rodriguez M. Carter JL, et al. Mayo Clin Proc. 1989 Jun;64(6):664-9. doi: 10.1016/s0025-6196(12)65345-2. Mayo Clin Proc. 1989. PMID: 2473360 Review.
Immunosuppressive drugs in multiple sclerosis: pro and con.
Ellison GW, Myers LW. Ellison GW, et al. Neurology. 1980 Jul;30(7 Pt 2):28-32. doi: 10.1212/wnl.30.7_part_2.28. Neurology. 1980. PMID: 6248818 Review. No abstract available.
[Immunosuppressive treatment in neurological disorders].
Aarli JA. Aarli JA. Tidsskr Nor Laegeforen. 1973 Jun 30;93(18):1395-7. Tidsskr Nor Laegeforen. 1973. PMID: 4356438 Review. Norwegian. No abstract available.
Immunosuppressive therapy in neurological diseases.
Cendrowski W, Riekkinen PJ, Rinne UK. Cendrowski W, et al. Ann Clin Res. 1974 Dec;6(6):323-9. Ann Clin Res. 1974. PMID: 4375431 Review. No abstract available.

See all similar articles

Cited by

Immunological treatment of multiple sclerosis.
Hughes RA. Hughes RA. J Neurol. 1983;230(2):73-80. doi: 10.1007/BF00313634. J Neurol. 1983. PMID: 6196462 Clinical Trial.
Plasmapheresis combined with interferon: an effective therapy for multiple sclerosis.
Medenica RD, Mukerjee S, Alonso K, Lazovic G, Huschart T. Medenica RD, et al. J Clin Apher. 1994;9(4):222-7. doi: 10.1002/jca.2920090405. J Clin Apher. 1994. PMID: 7538999 Free PMC article. Clinical Trial.
Short-term intensive cyclophosphamide treatment in multiple sclerosis. A retrospective controlled study.
Theys P, Gosseye-Lissoir F, Ketelaer P, Carton H. Theys P, et al. J Neurol. 1981;225(2):119-33. doi: 10.1007/BF00313325. J Neurol. 1981. PMID: 6164763
Four year double-blind controlled study of levamisole in multiple sclerosis.
Massaro AR, Cioffi RP, Laudisio A, Schiavino D, Mariani M. Massaro AR, et al. Ital J Neurol Sci. 1990 Dec;11(6):595-9. doi: 10.1007/BF02337444. Ital J Neurol Sci. 1990. PMID: 2081685 Clinical Trial.
The combination of cyclophosphamide plus interferon beta as rescue therapy could be used to treat relapsing-remitting multiple sclerosis patients-- twenty-four months follow-up.
Reggio E, Nicoletti A, Fiorilla T, Politi G, Reggio A, Patti F. Reggio E, et al. J Neurol. 2005 Oct;252(10):1255-61. doi: 10.1007/s00415-005-0857-1. Epub 2005 Jun 6. J Neurol. 2005. PMID: 15940386 Clinical Trial.

See all "Cited by" articles

Publication types

Actions
Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon